Mitochondrial Glutamine Metabolism Drives Epileptogenesis in Primary Hippocampal Neurons
All available antiseizure medications aim at symptomatic control of epilepsy, but there is no strategy to stop the development of the disease. The main reason is the lack of understanding of the epileptogenic mechanisms. Closing this knowledge gap is an essential prerequisite for developing disease-modifying therapies that can prevent the onset of epilepsy. Using primary cocultures of hippocampal neurons and glial cells derived from rat pups of either sex, we show that epileptiform paroxysmal depolarization shifts (PDS) induce neuronal glucose hypometabolism which is compensated for by increased glutaminolysis. Glutaminolysis not only provides sufficient ATP to support electrical activity but also leads to decreased vesicular glutamate release, thereby promoting neuronal hypersynchrony. Moreover, prolonged promotion of PDS increased neuronal arborization and synaptic density, which in combination with spontaneous recovery of neuronal glucose metabolism led to seizure-like discharge activity. Since inhibition of glutaminolysis did not prevent the PDS-induced morphogenesis but eliminated seizure-like activity, we propose that glutaminolysis is a causative process linking neuronal metabolism with electrical activity thereby driving epileptogenesis.
Authors
- Klaus Schicker (ORCID: https://orcid.org/0000-0002-3068-7830)
- Stefan Boehm (ORCID: https://orcid.org/0000-0002-0205-2459)
- Matej Hoťka (ORCID: https://orcid.org/0000-0002-0482-9401)
- Francesco Gentile (ORCID: https://orcid.org/0000-0002-1847-5608)
- Helmut Kubista (ORCID: https://orcid.org/0000-0002-5805-8649)
- Thomas Köcher
Institutions
- Vienna Biocenter (AT)
- Karl Landsteiner University of Health Sciences (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Journal of Neuroscience
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1523/jneurosci.0110-25.2025
- Citations
- 5
- Primary Topic
- Metabolism and Genetic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 6.59
Funders
- Austrian Science Fund